Description

Overall treatment response rates using composite IBS-SSS criteria are summarized for the synbiotic versus placebo comparison.

Figure 14

Chart

Source Paper

The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant …

Nutrients (2020)

PMID: 32635661

DOI: 10.3390/nu12071999

Cite This Figure

![Figure 14: Overall treatment response rates using composite IBS-SSS criteria are summarized for the synbiotic versus placebo comparison.]()

> Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." *Nutrients*, 2020. PMID: [32635661](https://pubmed.ncbi.nlm.nih.gov/32635661/)

<figure>
  <img src="" alt="Overall treatment response rates using composite IBS-SSS criteria are summarized for the synbiotic versus placebo comparison." />
  <figcaption>Figure 14. Overall treatment response rates using composite IBS-SSS criteria are summarized for the synbiotic versus placebo comparison.<br>  Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32635661/">32635661</a></figcaption>
</figure>

Preuves associées

Bifidobacterium longum pour Irritable Bowel Syndrome (IBS)

Note B · 4 études

Galactooligosaccharides (GOS) pour Irritable Bowel Syndrome (IBS)

Note B · 3 études

Lactobacillus acidophilus pour Irritable Bowel Syndrome (IBS)

Note B · 3 études

Fructooligosaccharides (FOS) pour Irritable Bowel Syndrome (IBS)

Note D · 2 études